Comparative in Vitro Transcriptomic Analyses of COVID-19 Candidate Therapy Hydroxychloroquine Suggest Limited Immunomodulatory Evidence of SARS-CoV-2 Host Response Genes.
doi 10.1101/2020.04.13.039263
Full Text
Open PDFAbstract
Available in full text
Date
April 14, 2020
Authors
Publisher
Cold Spring Harbor Laboratory